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A B S T R A C T
Background
Clinical trials of interventions designed to prevent severe falciparum malaria in children
require a clear endpoint. The internationally accepted definition of severe malaria is sensitive,
and appropriate for clinical purposes. However, this definition includes individuals with severe
nonmalarial disease and coincident parasitaemia, so may lack specificity in vaccine trials.
Although there is no ‘‘gold standard’’ individual test for severe malaria, malaria-attributable
fractions (MAFs) can be estimated among groups of children using a logistic model, which we
use to test the suitability of various case definitions as trial endpoints.
Methods and Findings
A total of 4,583 blood samples were taken from well children in cross-sectional surveys and
from 1,361 children admitted to a Kenyan District hospital with severe disease. Among children
under 2 y old with severe disease and over 2,500 parasites per microliter of blood, the MAFs
were above 85% in moderate- and low-transmission areas, but only 61% in a high-transmission
area. HIV and malnutrition were not associated with reduced MAFs, but gastroenteritis with
severe dehydration (defined by reduced skin turgor), lower respiratory tract infection (clinician’s
final diagnosis), meningitis (on cerebrospinal fluid [CSF] examination), and bacteraemia were
associated with reduced MAFs. The overall MAF was 85% (95% confidence interval [CI] 83.8%–
86.1%) without excluding these conditions, 89% (95% CI 88.4%–90.2%) after exclusions, and
95% (95% CI 94.0%–95.5%) when a threshold of 2,500 parasites/ll was also applied. Applying a
threshold and exclusion criteria reduced sensitivity to 80% (95% CI 77%–83%).
Conclusions
The specificity of a case definition for severe malaria is improved by applying a parasite
density threshold and by excluding children with meningitis, lower respiratory tract infection
(clinician’s diagnosis), bacteraemia, and gastroenteritis with severe dehydration, but not by
excluding children with HIV or malnutrition.
The Editors’ Summary of this article follows the references.
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Introduction
Severe falciparum malaria is an important end point for
preventative intervention trials in its own right, and as a
proxy for malaria-associated deaths. The current interna-
tionally accepted deﬁnition of severe malaria in children is
based mainly on the presence of a limited set of bedside or
laboratory observations in the presence of parasitaemia with
asexual-stage Plasmodium falciparum [1]. This deﬁnition was
derived from estimates of the associated risks of death [2]. It is
biased towards sensitivity, so is appropriate for clinical
purposes. However, because the signs on which it is based
are common in severe disease of any aetiology, and
asymptomatic carriage of parasites is common in endemic
areas, the deﬁnition lacks speciﬁcity. The measurable efﬁcacy
and absolute beneﬁt of a preventative intervention depend
critically on the speciﬁcity of the case deﬁnition. Some
comorbidities (e.g., malnutrition or HIV) might be risk
factors for severe malaria, and other comorbidities (e.g.,
bacteraemia) might be consequences of severe malaria.
There is no ‘‘gold standard’’ methodology with which to
identify individuals with ‘‘true’’ severe malaria rather than
severe disease with incidental parasitaemia, so malaria-
attributable fractions (MAFs) cannot be calculated by a
simple numerator and denominator approach. Instead, we
have ﬁtted the risk of severe disease to parasite density as a
logistic model, which allows MAFs to be estimated within
populations [3]. We have previously used this approach to
deﬁne a threshold level of parasite density to distinguish
asymptomatic parasitaemia (with a coincident, nonmalarial
cause of fever) from febrile malaria (that is attributable to the
parasitaemia) [4]. Exactly the same principles can be applied
to distinguishing severe disease attributable to malaria
parasites from severe disease attributable to other causes
but having coincident parasitisation. Children admitted to
hospital with signs of severe disease [2] were considered
‘‘cases,’’ and asymptomatic children in community studies
were considered ‘‘controls.’’ We applied logistic models to
determine the effect of a range of comorbidities on MAFs, so
as to quantify the effect of excluding these comorbidities on
the speciﬁcity of the deﬁnition of severe malaria. Although
MAFs are more widely used to indicate the fraction of febrile
cases in the community attributable to malaria [5], here we
use MAFs to refer to the fraction of severe disease resulting in
hospital admission that is attributable to malaria (and so
might be prevented by vaccination).
The case deﬁnition that we develop is not intended to limit
treatment options for severe malaria, since the balance of risk
and beneﬁt will always favour the use of antimalarial drugs
and other supportive clinical treatment in a sick child, even
when there is a low probability of severe malaria. Rather, it is
intended to maximize the discriminatory power of trials
conducted to evaluate interventions to prevent malaria. It
will also allow more accurate measurement of the disease
burden in epidemiological studies.
Methods
Location
The KEMRI Centre for Geographic Medicine Research
(Coast) is located at Kiliﬁ District Hospital, Kenya. Govern-
ment-employed clinical ofﬁcers admit children from the
hospital outpatient department to the paediatric ward where
research was conducted. The hospital serves ;240,000
people, who belong mainly to the Mijikenda group and are
rural farmers. Children in the surrounding area receive up to
120 mosquito bites infective for Plasmodium falciparum each
year [6]. Approval for the inpatient and community based
studies was given by the Kenyan Medical Research Institute
National Ethics Committee.
Clinical and Laboratory Methods
From 01 August 1998 to 30 July 2002 we prospectively
collected standardised clinical, anthropometric, and labora-
tory data on all children admitted to the paediatric wards
(described in detail elsewhere [7]). Subgroups of severe
malaria were examined. Coma was deﬁned as Blantyre coma
score below 3. Respiratory distress was deﬁned as the
presence of deep breathing. Severe anaemia was deﬁned as
a blood haemoglobin level under 50 g/l. MAFs for children
with two or more seizures in 24 h and prostration are given
separately. These deﬁnitions were applied consistently to
children at all transmission intensities. Children were
weighed on admission using an electronic scale. Weight for
age z scores were calculated using reference data from the
American National Centre for Health Statistics (NCHS) using
Epi Info 6.04b (US Centers for Disease Control and
Prevention, http://www.cdc.gov/epiinfo/Epi6/EI6dwni.htm).
Severe malnutrition was deﬁned as a weight for age z score
below3 or bipedal oedema and characteristic skin and hair
changes. Lower respiratory tract infection (LRTI) was deﬁned
by the clinician’s diagnosis on discharge, using a chest X-ray
where possible, although WHO integrated management of
childhood illness (IMCI) deﬁnitions for mild and severe LRTI
were also considered [8]. Clinical data were available for all
children.
Complete blood counts were performed using an automat-
ed counter (Beckman/Coulter, http://www.beckmancoulter.
com/). Thick and thin blood smear was stained with 10%
Giemsa and examined at 1,0003 magniﬁcation for asexual
forms of P. falciparum and results expressed per microliter
using the automated red and white cell indices.
Blood was aerobically cultured for pathogenic bacteria
(BACTEC, Becton-Dickinson, http://www.bd.com/) as previ-
ously described [7]. Bacterial species likely to represent
contamination were excluded from the deﬁnition of bacter-
aemia. Blood cultures were successfully obtained from 100%
of the children in this study, with a contamination rate of
14%. Lumbar puncture was guided by a clinical protocol [9],
and was conducted on 78% of children with signs of cerebral
malaria. Lumbar punctures were not done where there were
signs of cerebral herniation or the child died before the
lumbar puncture could be performed. Meningitis was deﬁned
as a positive CSF culture, a positive CSF latex agglutination
test, bacteria seen on CSF Gram stain, or a CSF leukocyte
count above 50 cells/ll [10,11]. HIV status was determined at
the end of the study using stored, anonymised plasma samples
systematically collected for all admissions with an invasive
bacterial infection and all admissions after 01 October 1999
using ELISA. PCR was used to conﬁrm infection in children
below the age of 18 mo. An HIV status was assigned to 92% of
all children with severe malaria admitted after October 1999.
Children enrolled before October 1999 were not included in
the analysis of HIV comorbidity.
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Clinical Management
Children were managed on the 35-bed general paediatric
ward and six-bed high-dependency ward. Children with
impaired consciousness or respiratory distress were normally
admitted to the high-dependency unit. Children on the high-
dependency unit were treated with intravenous quinine and
intravenous penicillin and chloramphenicol until the CSF
and/or blood culture results were known.
Children with severe anaemia, but without impaired
consciousness or respiratory distress, were normally treated
on the general paediatric ward. Blood transfusion was given
according to WHO guidelines and malaria was treated with
sulphamethoxazole-pyrimethamine. Research clinicians pro-
vided 24-h clinical cover of both the high-dependency unit
and the general paediatric ward, and admissions were
reviewed at least daily.
Community Survey Data
Data were collected between 1997 and 2006 during seven
cross-sectional surveys conducted at three different locations
within the district. Four were conducting during the rainy
season, three during the dry season. The three areas
(Ngerenya, Chonyi, and Junju) were chosen to represent
relatively low-, moderate-, and high-transmission intensities
respectively. Entomological inoculation rates were 10, 22–53,
and 42 infective bites/person/year, respectively [6], and the
prevalence of asymptomatic parasitaemia was 24.9% (95% CI
23%–27%), 40.5% (95% CI 39%–43%), and 71% (95% CI
66%–76%), respectively [4,12]. The numbers of observations
available by age group and location are shown in Table 1.
Children who were febrile or unwell at the time of the cross-
sectional survey were treated as clinically indicated and
excluded from analysis. Data were available for both rainy
and dry seasons in each study area. Children in Junju were
recruited for a Phase IIb vaccine trial, so limiting the age
range and number of children studied [12].
Participants
The initial study was limited to children from three
speciﬁed locations according to the availability of community
cross-sectional surveys. These children were admitted or had
blood samples taken in the community between 01 August
1998 and 01 August 2005. 1,422 children were admitted to
Kiliﬁ District Hospital with signs of severe disease during this
period, and 4,853 samples were taken in the community. The
distribution by age and location of these children is given in
Table 1.
To study comorbidities and clinical presentations, a more
restricted subset of these children was used, for whom
detailed clinical information was available. These children
were admitted between 01 August 1998 and 30 July 2002.
1,361 children had signs suggestive of severe disease.
Analysis
Parasite densities from the children with signs of severe
disease (considered ‘‘cases’’) and from children in cross-
sectional surveys (considered ‘‘controls’’) were used to model
the relationship between parasite density and severe disease.
The method has been described previously [5]. Brieﬂy, a
logistic regression model was used in which log(p/1  p)¼ a þ
bxs, where p is the probability of severe disease (i.e., inpatients
with severe disease are treated as ‘‘positive’’ and well children
in cross-sectional surveys as ‘‘negative’’), x is the density of
parasitaemia, and s is the power function, which improves the
numerical stability of the maximum likelihood estimation.
The coefﬁcient b in the logistic model can then be used to
calculate the risk of malaria for each individual. The risks of a
group of individuals can be summed to estimate the
proportion of the group having ‘‘true’’ severe malaria rather
than another cause of severe disease with coincident para-
sitaemia. This gives the positive predictive value, or MAF, for
the group analysed. Sensitivity and speciﬁcity can then be
calculated from the MAFs.
The model was repeated in different age groups, locations,
and for different comorbidity patterns. Conﬁdence intervals
(CIs) were estimated by bootstrapping, using 5,000 iterations.
The impact of age and location was modelled on a data set
covering 1997–2004, restricted to cases of severe disease
presenting from the three geographical locations used to
establish the cross-sectional datasets. The impact of various
comorbidities was studied on all admissions between 1998
and 2002, when systematically collected information on other
clinical features was available to deﬁne comorbidity. The
dataset was not large enough to allow models for comorbidity
to be corrected by age, location, and season.
Results
Case Definitions by Age and Location
MAFs and sensitivities are shown in Figure 1. At low
transmission intensity, MAFs for severe disease with any
parasitaemia were 94% (95% CI 90%–98%) for infants and
88% (95% CI 82%–94%) for 2–4 year olds. In the moderate
transmission area the MAF for any parasitaemia was 86%
(95% CI 77%–95%) in infants, but this fell to 64% (95% CI
51%–77%) in the 2–4 y age group. Under high transmission,
MAFs were much lower at 45% (95% CI 30%–60%) in 1- to 2-
y-olds. Using a threshold of at least 2,500 parasites/ll to
identify cases would have increased the MAFs from 86% to
93% (95% CI 88%–99%) and from 64% to 80% (95% CI
70%–88%) for infants and 2- to 4-y-olds, respectively, in the
moderate-transmission area. However, among 1- to 2-y-olds
in the high-transmission area, the MAF was only 61% (95% CI
Table 1. Number of Observations Available for Analysis of
Parasitaemia in Afebrile Children from Cross-sectional Surveys
and Severe Malaria Cases, by Location and Age Group
Transmission
Conditions
Age Group Observations:
Afebrile
Observations:
Severe Malaria
Low 3–12 mo 383 109
1–2 y 518 94
2–4 y 1,077 108
4–6 y 1,087 47
Moderate 3–12 mo 211 287
1–2 y 248 177
2–4 y 486 150
4–6 y 465 49
High 3–12 mo 0 0
1–2 y 78 199
2–4 y 162 146
4–6 y 143 56
doi:10.1371/journal.pmed.0040251.t001
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46%–76%) with a threshold of 2,500 parasites/ll, and 89%
(95% CI 79%–99%) with a threshold of 50,000 parasites/ll.
Although a threshold of 50,000 included nearly 100% of the
true malaria cases in the high-transmission area, it reduced
sensitivity in the low-transmission areas to only 50%. A
threshold of 2,500 parasites/ll would have a sensitivity of 90%
or more. Overall, the MAF for all severe malaria cases was
85% (95% CI 84%–86%) at any parasitaemia level, and 93%
(95% CI 92%–94%) with a threshold . 2,500 parasites/ll. A
threshold of 2,500 parasites/ll gives a sensitivity of 90% or
more at moderate- and high-transmission intensities, but
80% in low-transmission areas.
Case Definitions by Severe Malaria Syndrome
The MAFs (with CIs) for children with different clinical
features and comorbidities are shown in Table 2. Among
subgroups of severe malaria, the MAFs were highest in coma,
intermediate for severe anaemia, and lowest for respiratory
distress. The MAFs for children with a history of seizures and
for children with impaired consciousness were similar.
Case Definitions by Season
When months associated with greater malaria transmission
(‘‘rainy season’’) and months associated with lower malaria
transmission (‘‘dry season’’) were analysed separately, the
MAFs for all parasitaemic children were higher during the
rainy season, but at a threshold of 2,500 parasites/ll, the MAFs
during the rainy and dry seasons were similar.
Case Definitions by Comorbidity
HIV and malnutrition were associated with only slight
reductions in MAFs. The lowest MAFs were seen among
children with meningitis, and children with bacteraemia had
moderate reductions in MAFs. Gram-negative and gram-
positive bacteraemia were associated with markedly different
MAFs (Table 2). However, the symptoms and signs of
gastroenteritis were associated with differing MAFs. Among
children with vomiting, the MAF was similar to that seen for
all cases, but a history of diarrhoea (deﬁned as 3 loose stools
in 24 h) was associated with a lower MAF. However, this
reduction was largely accounted for by children with signs of
severe dehydration. Among children with documented
reduced skin turgor, the MAFs were lower than for children
with a history of diarrhoea. Children with diarrhoea but
normal skin turgor had MAFs similar to the admissions
without comorbidity.
Children for whom a ﬁnal diagnosis of LRTI was made by a
clinician had a low MAF. However, low MAFs were not seen
among children who met WHO IMCI criteria for LRTI of any
Figure 1. The Attributable Fractions and Sensitivity for Severe Malaria
Fractions are shown for varying parasite density thresholds according to age group and location. Malaria-attributable fractions are indicated by closed
circles, sensitivity by open circles.
doi:10.1371/journal.pmed.0040251.g001
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severity. Although a lower MAF was seen among children in
whom crepitations were heard on chest auscultation, the
MAF among children with a clinician’s diagnosis of LRTI was
lower still.
The overall MAF rose from 85% (95% CI 83.8%–86.1%) to
89% (95% CI 88.4%–90.2%) after excluding gastroenteritis
with severe dehydration, LRTI, meningitis, and bacteraemia,
and then to 95% (95% CI 94%–95.5%) when a threshold of
2,500 parasites/ll was used. The sensitivity fell to 80% (95%
CI 77%–83%) overall.
Discussion
Children with falciparum parasitaemia in association with
clinical signs of severe malaria had an MAF of 85%, which
rose to 95% when a threshold of 2,500 parasites/ll was
applied and children with meningitis, lower respiratory tract
infection (clinician’s diagnosis), bacteraemia, and gastro-
enteritis with severe dehydration were excluded. Excluding
children with HIV or malnutrition did not improve the case
deﬁnition.
We have previously described severe falciparum malaria in
children admitted to hospital by identifying the children at
greatest risk of death [2]. However, asymptomatic para-
sitaemia is common in malaria-endemic areas, and the
clinical features of severe malaria can be similar to those of
other severe illnesses. A simple clinical deﬁnition therefore
lacks speciﬁcity. This low-speciﬁcity deﬁnition is appropriate
for clinical care, but not for epidemiological studies describ-
ing the disease burden or measuring the efﬁcacy of
intervention. In previous studies we used the logistic model
ﬁrst proposed by Smith and Schellenberg [5] to deﬁne the
MAFs among children with uncomplicated fever. The optimal
threshold among children aged 1 y and over was 2,500
parasites/ll in the low- and moderate-transmission areas, and
any density of parasitaemia in infants [4]. In our analysis of
severe inpatient malaria, we found very similar patterns for
the variation of thresholds by transmission intensity and age
in deﬁning severe malaria.
It is impractical to deﬁne a threshold parasitaemia for
every age group, village, and season, so any threshold used in
a trial or epidemiological study must inevitably be a
compromise. Higher thresholds were required in older age
groups, and at higher transmission intensities. Data from the
high-transmission area support a high threshold (at least
10,000 and perhaps even 50,000 parasites/ll), but this would
be associated with a large reduction in sensitivity if applied to
the low- and moderate-transmission areas, and transmission
may vary considerably even in a restricted area [6]. Based on
our overall data set, the best compromise between sensitivity
and speciﬁcity in deﬁning severe malaria among children
below 6 y of age was achieved with a threshold of 2,500
Table 2. Malaria-Attributable Fractions for Children Admitted with the Clinical Features Given and Any Parasitaemia, or .2,500
Parasites/ll
Category Feature .0 Parasites/ll .2,500 Parasites/ll
MAF (95% CI) MAF (95% CI)
All cases 84.9% (83.8%–86.1%) 92.7% (92%–93.4%)
Exclusionsa applied 89.3% (88.4%–90.2%) 95% (94%–95.5%)
Clinical presentation Coma 91.9% (90.7%–93%) 95.8% (95.1%–96.5%)
Severe anaemia only 87.2% (86%–88.3%) 93.8% (93.1%–94.5%)
Respiratory distress only 81.4% (79%–83.8%) 90.3% (88.7%–91.8%)
Prostration 92.4% (91.4%–93.4%) 96.2% (95.6%–96.8%)
Two or more seizures 94.7% (93%–95.8%) 97.2% (96.6%–97.9%)
Season Rainy Season 86.8% (85.7%–88.0%) 93.2% (92.4%–94.0%)
Dry Season 81.1% (78.5%–83.6%) 92.4% (91.1%–93.7%)
Signs or symptoms of gastroenteritis Vomiting 83.3% (81.5%–84.9%) 91.9% (90.9%–92.9%)
Diarrhoea 73.4% (69%–77.5%) 83.1% (80%–86%)
Reduced skin turgor 57.6% (43%–70.5%) 68.4% (54.8%–79%)
Sunken eyes 63.1% (54.5%–70.7%) 76.8% (70%–82.6%)
Diarrhoea, skin turgor normal 83.5% (78.4%–87.9%) 89.3% (85.2%–92.5%)
Signs or symptoms of LRTI LRTI diagnosed by clinician 48.7% (35.7%–59.5%) 62.4% (49.6%–72.5%)
Cyanosis or hypoxia 86.2% (83.5%–88.7%) 91.8% (89.9%–93.4%)
Cough 81.5% (79.6%–83.3%) 90.2% (89%–91.3%)
Severe LRTI (by IMCI) 83.5% (81%–85.4%) 92.1% (90%–93.9%)
Mild LRTI (by IMCI) 88% (85.6%–90.4%) 94.2% (92.9%–95.6%)
Raised respiratory rate 82% (80.2%–83.7%) 90.6% (89.5%–91.7%)
Crackles 62% (51.7%–71.3%) 80% (72.2%–85.7%)
Hypoxia (saturations ,90%) 86% (82.9–88.6%) 91.7% (89.8%–93.4%)
Elevated WBC (.15) 85.8% (84%–87%) 91.9% (91.0%–92.9%)
Other comorbidity HIV 84.3% (80%–88%) 92% (89.6%–94.1%)
Malnutrition (z score ,-3) 76.9% (72.3%–80.9%) 85.1% (81.5%–87.9%)
Bacteraemia 63.5% (54.7%–70.5%) 82% (76.5%–86.9%)
Meningitis (CSF findings) 22.7% (2.7%–46.7%) 32.5% (6.5%–58%)
Gram-negative bacteraemia 84.9% (83.7%–86.1%) 92.7% (92%–93.5%)
Gram-positive bacteraemia 40.4% (24.4%–55.7%) 57.6% (40%–71%)
aChildren with reduced skin turgor, LRTI diagnosed by a clinician, bacteraemia, or meningitis are excluded.
doi:10.1371/journal.pmed.0040251.t002
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parasites/ll. This threshold reduces sensitivity to 80%, and so
may reduce the power of a study. However, a low speciﬁcity
reduces the apparent efﬁcacy, and so also reduces power. We
examined the outcome of these competing effects for our
data. If no exclusion criteria or threshold parasitaemia were
used on this data set, an intervention with 50% efﬁcacy would
have an apparent efﬁcacy of 43% and require n ¼ 5,500 for
90% power. After applying exclusion criteria and the
threshold of 2,500 parasites/ll, the apparent efﬁcacy would
be 48% (n ¼ 6,000 for 90% power). Although the apparent
efﬁcacy estimate is more accurate (because the vaccine
cannot reduce the ‘‘nonmalaria’’ severe disease that is
included in the study end point), the sample size has
increased slightly because of reduced sensitivity. Were the
threshold parasitaemia applied without exclusion criteria, the
apparent efﬁcacy would be 46% (n ¼ 7,000 for 90% power).
However, the effect will depend critically on transmission
intensity and the incidence of severe nonmalarial disease
(e.g., during a cholera outbreak), so these calculations should
be considered illustrative rather than deﬁnitive.
Severe malaria comprises three distinct, though often
overlapping, clinical syndromes: impaired consciousness,
respiratory distress, and severe anaemia [2]. MAFs were
highest among children with coma, then severe anaemia, and
least with respiratory distress. However, a threshold of 2,500
parasites/ll gave MAFs of over 90% in all syndromes.
Children admitted with two or more seizures in 24 h had
very high MAFs, suggesting that malaria is the most common
cause of convulsions in the children studied.
Children with coexistent HIV or malnutrition should not
be excluded from a case deﬁnition of severe malaria, as the
high MAFs indicate that malaria is often the immediate
proximate cause of the life-threatening illness. A history of
diarrhoea was associated with reduced MAFs, but this effect
was found mainly among children with reduced skin turgor (a
sign of intracellular dehydration). Children with diarrhoea
but normal skin turgor had a high MAF. Thus, skin turgor
appears to distinguish severe dehydration with extravascular
ﬂuid depletion in gastroenteritis from intravascular ﬂuid
depletion without signs of marked tissue dehydration in
malaria [13].
A clinical syndrome of LRTI at admission (according to
WHO IMCI guidelines) was not associated with reduced
MAFs. However, when clinicians made a ﬁnal diagnosis of
LRTI, they successfully identiﬁed a group of children with low
MAFs. This is surprising, since the deep breathing produced
by malaria-related acidosis is easily confused with respiratory
disease [2]. Of the signs and symptoms examined, only
crackles on auscultation of the chest were associated with
lower MAFs. This observation is also surprising, considering
the high interobserver variability for ﬁndings on lung
auscultation [14,15]. Since clinical criteria alone were
insufﬁcient to predict comorbidity, it is likely that the results
of investigations contributed signiﬁcantly to the clinician’s
diagnoses. However, children with bacteraemia received a
primary diagnosis of bacteraemia rather than LRTI, so did
not contribute. A high white blood cell count was not
associated with a reduced MAF. Data on chest X-ray ﬁndings
were not available for this analysis, and may have contributed
to the overall clinical diagnosis of LRTI. However, this
possibility is speculative, and other factors may have
contributed to the clinical assessment.
Proven bacterial meningitis should exclude a case from
consideration as severe malaria. Among children with
bacteraemia the MAFs were reduced, but not by as much as
those for meningitis or LRTI. It may be that bacteraemia is
the primary cause of severe disease in some children but a
consequence of severe malaria in other children. When
enteric gram-negative organisms and gram-positive organ-
isms were examined separately, the reduction in MAF was
conﬁned to gram-positive organisms. Bacteraemia with
enteric organisms may often be a consequence of malaria
infection in this group of children, whereas gram-positive
bacteraemia may be unrelated.
What are the limitations of this study? Data from all
admissions with severe disease during the study period were
used to examine the impact of comorbidity, but data used to
establish patterns of asymptomatic parasitaemia in the
community were necessarily from a subsample, limited
geographically and temporally. It is possible that the true
distribution of asymptomatic parasitaemia in the whole of
Kiliﬁ district might be different from that used in this
analysis. Although this might bias the calculated MAFs, this
consideration applies equally to each subgroup for which
MAFs were estimated. Conclusions based on comparisons
between comorbidities and all cases are therefore still
justiﬁed.
Hospital inpatient studies on the correlation between
diseases are vulnerable to Berkson’s bias [16]. If, for example,
the presence of incidental parasitaemia were to increase the
probability of admission among primary cases of malnutri-
tion, then a biased association would occur between
malnutrition and parasitaemia. This artefactual association
could bias the MAF estimate upward in the malnutrition
subgroup. However, for the majority of children admitted to
Kiliﬁ District Hospital the malaria slide performed after
admission is the ﬁrst malaria investigation of their illness. If
the presence of malnutrition increases the probability of
admission among primary cases of malaria, the MAFs would
be increased among malnutrition cases. However, the
objective of the study was to deﬁne a group of patients with
a diagnosis of severe malaria in whom the MAF was
optimised. Malaria would nevertheless be the immediate
proximate cause of admission, and these cases might be
prevented by an effective vaccine. As it turned out, some of
the more visible conditions with the greatest potential for a
biased association (LRTI and gastroenteritis) were also those
that had the smallest MAF estimates and were excluded from
the ﬁnal end-point deﬁnition.
Data on funduscopy was not available in this study. Retinal
changes speciﬁc to cerebral malaria are well described [17],
but require specialist examination techniques by experienced
operators. Further evaluation of direct funduscopy by general
clinicians is desirable, but these techniques are unlikely to be
part of a case deﬁnition in many ﬁeld sites, and it is difﬁcult
to examine the retina fully in conscious children. Further-
more, data were not available in Kiliﬁ during this study.
Future studies calculating MAFs should collect data on
specialist and nonspecialist funduscopy to evaluate the
speciﬁcity of the technique in deﬁning severe malaria.
The protocol for HIV testing changed during the study, but
the MAF among HIV-positive children was calculated from
the group admitted after October 1999. HIV data were
PLoS Medicine | www.plosmedicine.org August 2007 | Volume 4 | Issue 8 | e2511338
Case Definitions of Severe Malaria
available on 92% of these children, and so signiﬁcant bias
seems unlikely.
In an single district in Kenya, with transmission ranging
from less than one up to 120 infective bites per year, typical
of the majority of transmission setting in sub-Saharan Africa
[6,18], a threshold of 2,500 parasites/ll to deﬁne severe
malaria offers a reasonable compromise between sensitivity
and positive predictive value in children below 6 y of age.
This approach now needs to be veriﬁed in other settings. The
threshold parasitaemia is more likely to vary than is the
impact of comorbidities, so analysis of children admitted for
severe malaria and of community controls in other locations
would still be of value even without detailed data on
comorbidity. Children with gastroenteritis and severe dehy-
dration (deﬁned by reduced skin turgor), LRTI (deﬁned by
chest X-ray and clinical judgement), and proven meningitis
should be excluded. Bacteraemia could be included if a
higher parasite density threshold is used, but not otherwise.
HIV and malnutrition should not be exclusion criteria. In any
intervention study, it will be essential to determine the rates
of both nonmalaria- and malaria-associated bacteraemia,
gastroenteritis, and LRTI, since it is possible that one effect of
vaccination will be to convert parasitaemic comorbidity to
aparasitaemic comorbidity. An effective vaccination may
even alter the appropriate parasitaemia threshold. An
analysis of MAFs should be part of the analysis plan for trials
or epidemiological studies of severe malaria, conducted
separately for the intervention and the control arm of the
trial. Where prior data exist, an analysis to conﬁrm that 2,500
parasites per microliter of blood is an appropriate threshold
to deﬁne severe malaria would be an advantage.
Acknowledgments
This paper is published with the permission of the director of KEMRI.
J. Berkley held a Wellcome Trust Training Fellowship in Clinical
Tropical Medicine (053439). K. Maitland is a Wellcome Trust
Principal Fellow (062372). C. Newton is a Wellcome Trust Senior
Clinical Fellow (070114).
Author contributions. The manuscript was written by P. Bejon, J.
Berkley, C. Newton, and K. Marsh. Laboratory studies were conducted
by B. Lowe. Clinical support was given by T. Mwangi, I. Mwangi, K.
Maitland, J. Scott, M. English, N. Peshu, and C. Newton. Inpatient data
were collected by K. Maitland, J. Scott, M. English, C. Newton, and K.
Marsh. Outpatient data were collected by T. Mwangi, E. Ogada, and T.
Williams. P. Bejon analysed the data. K. Maitland, J. Scott, and C.
Newton contributed to interpretation of the results. All authors
approved the final manuscript. P. Bejon had full access to all of the
data in the study and takes responsibility for the integrity of the data
and the accuracy of the data analysis.
References
1. World Health Organization, Communicable Diseases Cluster (2000) Severe
falciparum malaria. Trans R Soc Trop Med Hyg 94: S1–S90.
2. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, et al. (1995)
Indicators of life-threatening malaria in African children. N Engl J Med
332: 1399–1404.
3. Smith T, Schellenberg JA, Hayes R (1994) Attributable fraction estimates
and case deﬁnitions for malaria in endemic areas. Stat Med 13: 2345–2358.
4. Mwangi TW, Ross A, Snow RW, Marsh K (2005) Case deﬁnitions of clinical
malaria under different transmission conditions in Kiliﬁ District, Kenya. J
Infect Dis 191: 1932–1939.
5. Schellenberg JR, Smith T, Alonso PL, Hayes RJ (1994) What is clinical
malaria? Finding case deﬁnitions for ﬁeld research in highly endemic areas.
Parasitol Today 10: 439–442.
6. Mbogo CM, Mwangangi JM, Nzovu J, Gu W, Yan G, et al. (2003) Spatial and
temporal heterogeneity of Anopheles mosquitoes and Plasmodium falciparum
transmission along the Kenyan coast. Am J Trop Med Hyg 68: 734–742.
7. Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, et al. (2005)
Bacteremia among children admitted to a rural hospital in Kenya. N Engl
J Med 352: 39–47.
8. WHO (2002) Improving child health in the community. WHO/FCH/CAH/
02.12 Geneva: WHO. Available: http://www.who.int/child-adolescent-health/
publications/CHILD_HEALTH/WHO_FCH_CAH_02.12.htm. Accessed:
6 July 2007.
9. Berkley JA, Versteeg AC, Mwangi I, Lowe BS, Newton CR (2004) Indicators
of acute bacterial meningitis in children at a rural Kenyan district hospital.
Pediatrics 114: e713–e719.
10. Berkley JA, Mwangi I, Ngetsa CJ, Mwarumba S, Lowe BS, et al. (2001)
Diagnosis of acute bacterial meningitis in children at a district hospital in
sub-Saharan Africa. Lancet 357: 1753–1757.
11. Wright PW, Avery WG, Ardill WD, McLarty JW (1993) Initial clinical
assessment of the comatose patient: Cerebral malaria vs. meningitis.
Pediatr Infect Dis J 12: 37–41.
12. Bejon P, Mwacharo J, Kai O, Mwangi T, Milligan P, et al. (2006) A phase 2b
randomised trial of the candidate malaria vaccines FP9 ME-TRAP and
MVA ME-TRAP among children in Kenya. PLoS Clin Trials 1: e29. doi:10.
1371/journal.pctr.0010029
13. Maitland K, Pamba A, Newton CR, Levin M (2003) Response to volume
resuscitation in children with severe malaria. Pediatr Crit Care Med 4: 426–
431.
14. Brooks D, Thomas J (1995) Interrater reliability of auscultation of breath
sounds among physical therapists. Phys Ther 75: 1082–1088.
15. Hay AD, Wilson A, Fahey T, Peters TJ (2004) The inter-observer agreement
of examining pre-school children with acute cough: A nested study. BMC
Fam Pract 5: 4.
16. Feinstein AR, Walter SD, Horwitz RI (1986) An analysis of Berkson’s bias in
case-control studies. J Chronic Dis 39: 495–504.
17. Beare NA, Taylor TE, Harding SP, Lewallen S, Molyneux ME (2006) Malarial
retinopathy: A newly established diagnostic sign in severe malaria. Am J
Trop Med Hyg 75: 790–797.
18. Hay SI, Rogers DJ, Toomer JF, Snow RW (2000) Annual Plasmodium
falciparum entomological inoculation rates (EIR) across Africa: Literature
survey, internet access and review. Trans R Soc Trop Med Hyg 94: 113–127.
PLoS Medicine | www.plosmedicine.org August 2007 | Volume 4 | Issue 8 | e2511339
Case Definitions of Severe Malaria
Editors’ Summary
Background. Malaria is responsible for over a million deaths every year,
and most of those who die are children in Africa. Until a few years ago,
not enough research was being done on malaria, but now many
researchers are active in this field. Doctors describe some cases of
malaria as being ‘‘severe.’’ Severe malaria in children is very hard to
diagnose precisely. Current protocols for diagnosing severe malaria are
very sensitive: that is, virtually all children who do have severe malaria
will be correctly diagnosed as such. However, the protocols are not very
specific: many children who do not have severe malaria, but whose
symptoms are instead caused by other diseases, will be defined as
suffering from severe malaria. This definition is acceptable for the clinical
care of sick children, because it ensures that antimalarial drugs are given
to all who might benefit from them, plus some additional children for
whom those drugs are not required. However, this definition is not
particularly useful for research purposes. When conducting a clinical trial
aimed at preventing cases of malaria, it is important to evaluate whether
the intervention being tested actually works. Therefore, a more specific
method of calculating the number of malaria cases within a population is
needed for this type of research.
Why Was This Study Done? The current definition for diagnosing
severe malaria includes a set of signs and symptoms that may be
observed at the bedside or as a result of laboratory investigation, along
with the detection of malaria parasites in the patient’s blood. However,
in many malarious areas, a large proportion of the population carries
malaria parasites without signs of disease; at the same time, the signs
and symptoms of malaria are shared with other diseases. The
investigators here wanted to find out whether they could develop an
accurate ‘‘case definition’’ of severe malaria that can be used in research.
What Did the Researchers Do and Find? In this study, two groups of
children were studied: first, 1,422 children admitted to the children’s
wards of the Kilifi District Hospital in Kenya, and second, 4,583 children
from the surrounding community. Blood samples were taken in order to
find out how common malaria parasites were in the children’s blood, and
standard clinical and laboratory data were also collected from the
children admitted to the hospital. The researchers then compared these
data using a computer and tried to find out whether, by excluding
certain children who had particular signs, symptoms, or observations,
from the diagnosis of severe malaria, they were able to improve the
accuracy of their definition. Essentially, for each patient group, the
authors calculated ‘‘malaria-attributable fractions,’’ i.e., the proportion of
individuals studied whose disease was likely caused by malaria.
The researchers found that in areas with low and moderate transmission
of malaria, the proportion of individuals whose disease could be
attributed to malaria was high—nearly 85%. In areas with a high
transmission rate of malaria, this fraction was much lower, but could be
improved by including only children with a high proportion of parasites
in their blood. Importantly, the researchers were also able to increase the
recognition of children with disease likely caused by malaria by
excluding individuals who had also been diagnosed with gastroenteritis,
lower respiratory tract infections, meningitis, and bacterial infection in
the blood. If all of these individuals were excluded—so only individuals
with more than 2,500 parasites per microliter in their blood were
regarded as having severe malaria—the ‘‘malaria-attributable fraction’’
rose to 95%.
What Do These Findings Mean? These findings should not be directly
used to change the clinical care of children with the signs and symptoms
of severe malaria, but rather can be used within a clinical trial to create a
‘‘case definition’’ of malaria particular to that trial. This ability will help
researchers more accurately find out whether the intervention being
tested in their trial really does help to prevent cases of malaria or not.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0040251.
 The World Health Organization Global Malaria Programme details the
organization’s activities in fighting malaria, and provides a number of
helpful resources; a factsheet on children and malaria is also available
 The US Centers for Disease Control and Prevention provides many
malaria resources
 General information about malaria, including illustrations, is available
from the‘‘Medline Plus’’ encyclopedia
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